Literature DB >> 9653608

Usefulness of revised fasting plasma glucose criterion and characteristics of the insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects.

Y Tanaka1, Y Atsumi, T Asahina, K Hosokawa, K Matsuoka, J Kinoshita, T Onuma, R Kawamori.   

Abstract

OBJECTIVE: To examine the usefulness of the revised criterion for fasting plasma glucose (FPG) in the diagnosis of diabetes recommended by the American Diabetic Association (ADA) (126 mg/dl, 7 mmol/l), and to characterize insulin response during the 75-g oral glucose tolerance test (OGTT) in newly diagnosed Japanese diabetic subjects. RESEARCH DESIGN AND METHODS: A series of 2,121 Japanese subjects underwent a 75-g OGTT (0-3 h) and were divided into three groups (normal glucose tolerance [NGT], impaired glucose tolerance [IGT], and diabetes mellitus [DM] according to the current World Health Organization criteria. After the cutoff values of FPG that distinguish NGT and IGT from diabetes were analyzed, the usefulness of the ADA criterion for FPG was examined by comparing diagnostic parameters (sensitivity, specificity, and accuracy) with those for the cutoff value of 140 mg/dl. To assess insulin response, both the insulinogenic index (IsIx), a marker of early secretion, and the area under the insulin response curve (AUCins), a marker of total secretion, were compared between the DM, NGT, and IGT groups.
RESULTS: First, the FPG cutoff value distinguishing NGT from diabetes was 109 mg/dl. An FPG of 126 mg/dl showed a higher sensitivity (0.52 vs. 0.31), the same specificity (1.00), and a higher accuracy (0.82 vs. 0.74) than an FPG of 140 mg/dl, and it had a higher specificity (1.00 vs. 0.86) with a slightly lower accuracy (0.82 vs. 0.85) than an FPG of 109 mg/dl. Second, the FPG cutoff value differentiating IGT from diabetes was 113 mg/dl. An FPG of 126 mg/dl showed a higher sensitivity (0.52 vs. 0.31) and accuracy (0.80 vs. 0.74) and a similar specificity (0.97 vs. 1.00) compared with an FPG of 140 mg/dl, and it had a higher specificity (0.97 vs. 0.82) with the same accuracy (0.80) as an FPG of 113 mg/dl. Third, the DM group showed the lowest IsIx among the three groups at all FPG values. The AUCIns in the DM group increased along with FPG, reached the maximum level at an FPG of 110 mg/dl, and declined thereafter. AUCIns was higher in the DM group than in the NGT group at FPG values > or = 100 mg/dl.
CONCLUSIONS: The revised ADA criterion for FPG of 126 mg/dl may improve diagnostic sensitivity without loss of specificity in Japanese diabetic subjects when compared with an FPG criterion of 140 mg/dl. Although early insulin secretion was impaired, total insulin secretion did not seem to be reduced in newly diagnosed Japanese diabetic subjects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9653608     DOI: 10.2337/diacare.21.7.1133

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  8 in total

Review 1.  Diabetes in Japan.

Authors:  Takahisa Hirose; Ryuzo Kawamori
Journal:  Curr Diab Rep       Date:  2005-06       Impact factor: 4.810

2.  New ADA criteria in the Korean population: fasting blood glucose is not enough for diagnosis of mild diabetes especially in the elderly.

Authors:  Y H Choi; Y B Ahn; K H Yoon; M I Kang; B Y Cha; K W Lee; H Y Son; S K Kang
Journal:  Korean J Intern Med       Date:  2000-12       Impact factor: 2.884

3.  Sustained Decrease of Early-Phase Insulin Secretion in Japanese Women with Gestational Diabetes Mellitus Who Developed Impaired Glucose Tolerance and Impaired Fasting Glucose Postpartum.

Authors:  Hiroko Katayama; Daisuke Tachibana; Akihiro Hamuro; Takuya Misugi; Koka Motoyama; Tomoaki Morioka; Shinya Fukumoto; Masanori Emoto; Masaaki Inaba; Masayasu Koyama
Journal:  Jpn Clin Med       Date:  2015-12-09

4.  Daily rice intake strongly influences the incidence of metabolic syndrome in Japanese men aged 40-59 years.

Authors:  Yoko Watanabe; Isao Saito; Yasuhiko Asada; Taro Kishida; Tatsuhiro Matsuo; Masamitsu Yamaizumi; Tadahiro Kato
Journal:  J Rural Med       Date:  2013-07-02

5.  Comparison of morning basal + 1 bolus insulin therapy (insulin glulisine + insulin glargine 300 U/mL vs insulin lispro + insulin glargine biosimilar) using continuous glucose monitoring: A randomized crossover study.

Authors:  Soichi Takeishi; Hiroki Tsuboi; Shodo Takekoshi
Journal:  J Diabetes Investig       Date:  2017-06-10       Impact factor: 4.232

6.  Comparison of baseline characteristics and clinical course in Japanese patients with type 2 diabetes among whom different types of oral hypoglycemic agents were chosen by diabetes specialists as initial monotherapy (JDDM 42).

Authors:  Kazuya Fujihara; Risa Igarashi; Satoshi Matsunaga; Yasuhiro Matsubayashi; Takaho Yamada; Hiroki Yokoyama; Shiro Tanaka; Hitoshi Shimano; Hiroshi Maegawa; Katsuya Yamazaki; Koichi Kawai; Hirohito Sone
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

7.  Comparison of sitagliptin with nateglinide on postprandial glucose and related hormones in drug-naïve Japanese patients with type 2 diabetes mellitus: A pilot study.

Authors:  Masumi Tanimoto; Akio Kanazawa; Takahisa Hirose; Tomoaki Yoshihara; Saeko Kobayashi-Kimura; Risa Nakanishi; Yuka Tosaka; Ruri Sasaki-Omote; Kyoko Kudo-Fujimaki; Koji Komiya; Fuki Ikeda; Yuki Someya; Tomoya Mita; Yoshio Fujitani; Hirotaka Watada
Journal:  J Diabetes Investig       Date:  2015-03-15       Impact factor: 4.232

8.  Comparison of clinical characteristics in patients with type 2 diabetes among whom different antihyperglycemic agents were prescribed as monotherapy or combination therapy by diabetes specialists.

Authors:  Kazuya Fujihara; Osamu Hanyu; Yoriko Heianza; Akiko Suzuki; Takaho Yamada; Hiroki Yokoyama; Shiro Tanaka; Hiroaki Yagyu; Hitoshi Shimano; Atsunori Kashiwagi; Katuya Yamazaki; Koichi Kawai; Hirohito Sone
Journal:  J Diabetes Investig       Date:  2015-07-26       Impact factor: 4.232

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.